BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,796 | -17.6% | 127,078 | -0.5% | 0.04% | -12.8% |
| Q2 2023 | $5,817 | +9.6% | 127,682 | -2.4% | 0.05% | +4.4% |
| Q1 2023 | $5,307 | -21.2% | 130,854 | -0.9% | 0.04% | -25.0% |
| Q4 2022 | $6,733 | -99.9% | 132,097 | +2.4% | 0.06% | -10.4% |
| Q3 2022 | $6,950,000 | -16.5% | 129,035 | -0.5% | 0.07% | -14.1% |
| Q2 2022 | $8,325,000 | -14.8% | 129,619 | +2.9% | 0.08% | +2.6% |
| Q1 2022 | $9,771,000 | -57.9% | 126,006 | -53.3% | 0.08% | -11.6% |
| Q4 2021 | $23,186,000 | +112.3% | 270,102 | +99.0% | 0.09% | -6.5% |
| Q3 2021 | $10,919,000 | -4.2% | 135,756 | -4.1% | 0.09% | +1.1% |
| Q2 2021 | $11,394,000 | +361.7% | 141,542 | +383.7% | 0.09% | -2.2% |
| Q1 2021 | $2,468,000 | +0.7% | 29,263 | -4.2% | 0.09% | 0.0% |
| Q4 2020 | $2,450,000 | -0.4% | 30,534 | -0.2% | 0.09% | -13.1% |
| Q3 2020 | $2,460,000 | -9.0% | 30,592 | -2.5% | 0.11% | -14.4% |
| Q2 2020 | $2,703,000 | -56.4% | 31,391 | -58.9% | 0.12% | -17.8% |
| Q1 2020 | $6,197,000 | -6.2% | 76,325 | -3.4% | 0.15% | +24.6% |
| Q4 2019 | $6,605,000 | +2.0% | 78,987 | +6.6% | 0.12% | -10.3% |
| Q3 2019 | $6,478,000 | +18.5% | 74,064 | +11.0% | 0.14% | +6.2% |
| Q2 2019 | $5,466,000 | +4.0% | 66,742 | +3.3% | 0.13% | +0.8% |
| Q1 2019 | $5,254,000 | +26.8% | 64,620 | +2.6% | 0.13% | +8.5% |
| Q4 2018 | $4,144,000 | -16.4% | 62,959 | -2.1% | 0.12% | -4.9% |
| Q3 2018 | $4,957,000 | +1.8% | 64,304 | -2.5% | 0.12% | +3.4% |
| Q2 2018 | $4,868,000 | +18.7% | 65,925 | +4.5% | 0.12% | +9.2% |
| Q1 2018 | $4,101,000 | +0.5% | 63,058 | -0.1% | 0.11% | -0.9% |
| Q4 2017 | $4,081,000 | +13.0% | 63,130 | +9.7% | 0.11% | -1.8% |
| Q3 2017 | $3,610,000 | +6.0% | 57,523 | +2.2% | 0.11% | 0.0% |
| Q2 2017 | $3,407,000 | +86.6% | 56,277 | +59.9% | 0.11% | +23.1% |
| Q1 2017 | $1,826,000 | +17.0% | 35,202 | -0.0% | 0.09% | +28.2% |
| Q4 2016 | $1,561,000 | +27.4% | 35,209 | +36.9% | 0.07% | 0.0% |
| Q3 2016 | $1,225,000 | -6.0% | 25,725 | -3.2% | 0.07% | -5.3% |
| Q2 2016 | $1,303,000 | +52.0% | 26,571 | +27.4% | 0.08% | -10.7% |
| Q1 2016 | $857,000 | +43.1% | 20,862 | +32.9% | 0.08% | +13.5% |
| Q4 2015 | $599,000 | -9.0% | 15,693 | -21.7% | 0.07% | +7.2% |
| Q3 2015 | $658,000 | -51.4% | 20,040 | +3.5% | 0.07% | -48.1% |
| Q2 2015 | $1,354,000 | +4.3% | 19,356 | +2.1% | 0.13% | -15.8% |
| Q1 2015 | $1,298,000 | +21.6% | 18,951 | +30.1% | 0.16% | -5.4% |
| Q4 2014 | $1,067,000 | -10.9% | 14,562 | -12.7% | 0.17% | -6.2% |
| Q3 2014 | $1,197,000 | +5.7% | 16,680 | +6.5% | 0.18% | +4.1% |
| Q2 2014 | $1,132,000 | +11.2% | 15,657 | +13.2% | 0.17% | -2.3% |
| Q1 2014 | $1,018,000 | +3.7% | 13,837 | -2.0% | 0.18% | +4.8% |
| Q4 2013 | $982,000 | +4.9% | 14,114 | -0.9% | 0.17% | -44.5% |
| Q3 2013 | $936,000 | -7.3% | 14,244 | -2.3% | 0.30% | -18.6% |
| Q2 2013 | $1,010,000 | -1.4% | 14,583 | +3.4% | 0.37% | +27.1% |
| Q1 2013 | $1,024,000 | +58.0% | 14,098 | +45.1% | 0.29% | +7.8% |
| Q4 2012 | $648,000 | +41.2% | 9,716 | +27.5% | 0.27% | -7.5% |
| Q3 2012 | $459,000 | +17.1% | 7,622 | +3.3% | 0.29% | +3.9% |
| Q2 2012 | $392,000 | -14.2% | 7,380 | -3.4% | 0.28% | -11.4% |
| Q1 2012 | $457,000 | +15.4% | 7,642 | -4.6% | 0.32% | +11.2% |
| Q4 2011 | $396,000 | -12.0% | 8,008 | 0.0% | 0.28% | -22.8% |
| Q3 2011 | $450,000 | +0.9% | 8,008 | +7.1% | 0.37% | +14.2% |
| Q2 2011 | $446,000 | +5.4% | 7,476 | -5.0% | 0.32% | +5.2% |
| Q1 2011 | $423,000 | +1.2% | 7,873 | -4.7% | 0.31% | -4.1% |
| Q4 2010 | $418,000 | – | 8,261 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |